Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Apellis Pharmaceuticals (APLS) Return on Assets (2020 - 2025)

Apellis Pharmaceuticals (APLS) has 6 years of Return on Assets data on record, last reported at 0.11% in Q4 2025.

  • For Q4 2025, Return on Assets rose 11.0% year-over-year to 0.11%; the TTM value through Dec 2025 reached 0.11%, up 11.0%, while the annual FY2025 figure was 0.12%, 11.0% up from the prior year.
  • Return on Assets reached 0.11% in Q4 2025 per APLS's latest filing, down from 0.05% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.05% in Q3 2025 and bottomed at 0.78% in Q3 2021.
  • Average Return on Assets over 5 years is 0.28%, with a median of 0.24% recorded in 2024.
  • Peak YoY movement for Return on Assets: skyrocketed 56bps in 2022, then plummeted -50bps in 2023.
  • A 5-year view of Return on Assets shows it stood at 0.45% in 2021, then surged by 77bps to 0.1% in 2022, then crashed by -484bps to 0.6% in 2023, then skyrocketed by 63bps to 0.22% in 2024, then surged by 48bps to 0.11% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Assets were 0.11% in Q4 2025, 0.05% in Q3 2025, and 0.28% in Q2 2025.